To evaluate the association between adjunctive systemic corticosteroid use and clinical outcomes in children hospitalized with orbital cellulitis, highlighting its significance in pediatric care.
Approach:
Key Findings:
Corticosteroid use did not significantly reduce hospital length of stay (mean difference −0.43 days), but was associated with increased risks of surgical intervention (RR 2.08), PICU admission (RR 1.82), and 30-day readmission (RR 2.53), raising concerns for clinical practice.
Interpretation:
Adjunctive corticosteroids do not shorten hospitalization and may increase adverse outcomes in pediatric orbital cellulitis; caution is advised in clinical application.
Limitations:
Most included studies were observational, leading to potential confounding and biases that may affect the results' reliability.
Conclusion:
High-quality randomized controlled trials are needed to clarify the role of corticosteroids in the management of pediatric orbital cellulitis, particularly focusing on specific outcomes.
Thomas Nydegger of Refractive MD Growth explains that although different stages along the patient journey can each stand on their own, they must support each other for a practice to succeed.